Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries

Open access
Mewes, Janne C., Steuten, Lotte M. G., Groeneveld, Iris F., de Boer, Angela G. E. M., Frings-Dresen, Monique H. W., IJzerman, Maarten J., van Harten, Wim H. · 2015 · BMC Cancer

Abstract

BACKGROUND: Return-to-work (RTW)-interventions support cancer survivors in resuming work, but come at additional healthcare costs. The objective of this study was to assess the budget impact of a RTW-intervention, consisting of counselling sessions with an occupational physician and an exercise-programme. The secondary objective was to explore how the costs of RTW-interventions and its financial revenues are allocated among the involved stakeholders in several EU-countries. METHODS: The budget impact (BI) of a RTW-intervention versus usual care was analysed yearly for 2015-2020 from a Dutch societal- and from the perspective of a large cancer centre. The allocation of the expected costs and financial benefits for each of the stakeholders involved was compared between the Netherlands, Belgium, England, France, Germany, Italy, and Sweden. RESULTS: The average intervention costs in this case were €1,519/patient. The BI for the Netherlands was €-14.7 m in 2015, rising to €-71.1 m in 2020, thus the intervention is cost-saving as the productivity benefits outweigh the intervention costs. For cancer centres the BI amounts to €293 k in 2015, increasing to €1.1 m in 2020. Across European countries, we observed differences regarding the extent to which stakeholders either invest or receive a share of the benefits from offering a RTW-intervention. CONCLUSION: The RTW-intervention is cost-saving from a societal perspective. Yet, the total intervention costs are considerable and, in many European countries, mainly covered by care providers that are not sufficiently reimbursed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-015-1912-7

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Structure of the budget impact model
Fig. 1 Structure of the budget impact modelCC BY · PubMed Central
Fig. 2 Results of the base case analysis. A negative budget impact indicates that the intervention is cost-saving. The positive budget impact for the cancer centre results from the situation that in the Netherlands, the costs for RTW are not reimbursed for most patients. Thus, if a hospital is offering the intervention they need to finance it themselves
Fig. 2 Results of the base case analysis. A negative budget impact indicates that the intervention is cost-saving. The positive budget impact for the cancer centre results from the situation that in the Netherlands, the costs for RTW are not reimbursed for most patients. Thus, if a hospital is offering the intervention they need to finance it themselvesCC BY · PubMed Central
Fig. 3 The impact of earlier RTW on the budget impact in 2020. From 2020 on a steady state is assumed
Fig. 3 The impact of earlier RTW on the budget impact in 2020. From 2020 on a steady state is assumedCC BY · PubMed Central
Fig. 4 Incentive in EU-countries for financing RTW for cancer patients. The stakeholders placed in the framed square have a financial incentive for financing RTW interventions. The more stakeholders are placed in the framed square, the greater the incentives for implementing RTW are. If this is the patient/the employee, this is less beneficial then when this is another stakeholder, as it is not feasible that the patients carries the costs for the intervention alone. HI = Health insurance, HO = Hospital or health care provider, E = Employer, S = State, PI = Pension insurance scheme, P = Patient/employee
Fig. 4 Incentive in EU-countries for financing RTW for cancer patients. The stakeholders placed in the framed square have a financial incentive for financing RTW interventions. The more stakeholders are placed in the framed square, the greater the incentives for implementing RTW are. If this is the patient/the employee, this is less beneficial then when this is another stakeholder, as it is not feasible that the patients carries the costs for the intervention alone. HI = Health insurance, HO = Hospital or health care provider, E = Employer, S = State, PI = Pension insurance scheme, P = Patient/employeeCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 1

  1. van KWF Kankerbestrijding SK. Kanker in Nederland tot 2020 - trends en prognoses. Amsterdam: Dutch Cancer Society; 2011.

Cited by

See all 26

Metadata

Authors
Mewes, J. C., Steuten, L. M. G., Groeneveld, I. F., de Boer, A. G. E. M., Frings-Dresen, M. H. W., IJzerman, M. J., & van Harten, W. H.
Affiliations
  • University of Twente (NL)
  • University of Washington (US)
  • Sophia Revalidatie (NL)
Venue
BMC Cancer
Published
2015-11-12
Volume
15
Issue
1
Pages
899-899
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2108729418
Cited by
23
References
19
Citations by year
2026: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 5
FWCI
7.25
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • University of Twente Research Information (acceptedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • University of Twente Research Information (submittedVersion, cc-by)
Funders
  • Deutsches Krebsforschungszentrum
  • University of Cambridge
  • Cambridge University Hospitals
  • KWF Kankerbestrijding
  • Institut Gustave-Roussy
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
return to work interventions, cancer survivors, budget impact, cost allocation, exercise programmes, productivity benefits, health care costs, cancer centers, reimbursement, cross-national comparison, European Union
MeSH terms
Adult, Cost-Benefit Analysis, Counseling, Efficiency, Europe, Exercise Therapy, Female, Humans, Male, Middle Aged, Neoplasms, Netherlands, Rehabilitation, Vocational, Health Care Costs, Survivors, Sick Leave, Return to Work

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries. https://app.cochat.ai/papers/10.1186/s12885-015-1912-7
The paper
Mewes, J. C., Steuten, L. M. G., Groeneveld, I. F., de Boer, A. G. E. M., Frings-Dresen, M. H. W., IJzerman, M. J., & van Harten, W. H. (2015). Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries. BMC Cancer. https://doi.org/10.1186/s12885-015-1912-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.